Judges issue competing rulings on abortion drug | WORLD
Sound journalism, grounded in facts and Biblical truth | Donate

Judges issue competing rulings on abortion drug

Bottles of misoprostol tablets. Associated Press/Photo by Allen G. Breed

Judges issue competing rulings on abortion drug

Unborn babies may have a chance for protection from the most common form of abortion. The Food and Drug Administration’s longstanding approval of an abortion drug has become uncertain after two U.S. district judges on Friday issued conflicting rulings on mifepristone, which is typically used in a regimen with another drug, misoprostol. Drug-induced abortions account for more than half of all abortions in the United States, according to statistics reported by the U.S. Centers for Disease Control and Prevention and the pro-abortion Guttmacher Institute, which directly polls abortion centers.

What are the details of the rulings? Trump-appointed U.S. District Judge Matthew Kacsmaryk on Friday evening ordered a hold on federal approval of mifepristone, which has been approved by the FDA since 2000. The same evening, Obama-appointed U.S. District Judge Thomas O. Rice essentially ordered the opposite, directing officials not to make any changes to restrict access to the drug.

Dig deeper: Read Sharon Dierberger’s report in WORLD Magazine about how a court challenge could block a major abortion drug.

Stephen Kloosterman

Stephen Kloosterman is the breaking news editor for WORLD. He is a graduate of Dordt University and the World Journalism Institute.


An actual newsletter worth subscribing to instead of just a collection of links. —Adam

Sign up to receive The Sift email newsletter each weekday morning for the latest headlines from WORLD’s breaking news team.

Please wait while we load the latest comments...